These findings implicate EglN2 as having pro-oncogenic functions in PCa, while suggesting that SPOP exerts tumor-suppressive effects, at least partially through its role in promoting EglN2 degradation. This evidence concerns the gene EGLN2 and posterior cortical atrophy.